Drugs / Autologous apoptotic cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02903212 | Mar 2023 → Jun 2024 | rheumatoid arthritis | Centre Hospitalier Universitaire de Besancon | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous apoptotic cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02903212 ↗ |
| Modality | Cell therapy | “Cell Therapy” NCT02903212 ↗ |